 |
Harbin Pharm. Set up Goals for Tenth Five-Year Plan
Harbin Pharmaceutical Group and its subsidiary Harbin Pharmaceutical Co., Ltd. (SSE: 600664) held the proseminar entitled "the capital market and product market for Harbin Pharmaceutical Group" in Shanghai on December 10. It was revealed that the company endeavors to become one of the 50 biggest profit-making pharmaceutical enterprises in the world during the tenth five-year plan period.
The goals for Harbin Pharmaceutical Group during the tenth five-year plan are to adjust its capital structure, to make two of its subsidiaries listed on the domestic and overseas stock markets, to make technological innovations, and to build up six production bases in order to make itself one of the 50 biggest profit-making pharmaceutical enterprises in the world, as was reported. (Panorama)
In This Section
|